Webcasts & Presentations

Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

March 18, 2024

Neurocrine Biosciences to Particpate at the UBS Virtual CNS Day 2024 Conference

Eiry Roberts, Chief Medical Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the UBS Virtual CNS Day Conference at 12:00 p.m. Eastern Time on Monday March 18, 2024.

OPEN WEBCAST

March 19, 2024

Neurocrine Biosciences to Particpate at the Stifel 2024 Virtual CNS Days Conference

Kyle Gano, Chief Business Development and Strategy Officer, and Grace Liang, Vice President of Clinical Development, will present at the Stifel 2024 Virtual CNS Days Conference at 2:00 p.m. Eastern Time on Tuesday March 19, 2024.

OPEN WEBCAST

March 13, 2024

Neurocrine Biosciences to Participate at the Barclays 26th Annual Global Healthcare Conference on March 13 in Miami

Kyle Gano, Chief Business Development and Strategy Officer, and Todd Tushla, Vice President of Investor Relations, will present at the Barclays 26th Annual Global Healthcare Conference at 10:15 a.m. Eastern Time on Wednesday March 13, 2024 in Miami.

OPEN WEBCAST

March 12, 2024

Neurocrine Biosciences to Participate at the Leerink Partners Global Biopharma Conference on March 12 in Miami

Matt Abernethy, Chief Financial Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the Leerink Partners Global Biopharma Conference at 8:40 a.m. Eastern Time on Tuesday March 12, 2024 in Miami.

OPEN WEBCAST